Active Ingredients
active ingredients (each tablet) Docusate Sodium 50 mg Sennosides 8.6 mg |
Stool Softener And Stimulant Laxative Tablet
FDA Label NDC 11673-209
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Target Corporation for the product Stool Softener And Stimulant Laxative (NDC 11673-209). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, inactive ingredients, purpose, indications and usage, warnings, dosage and administration, keep out of reach of children, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredients
CARNAUBA WAX, COLLOIDAL SILICON DIOXIDE, CROSCARMELLOSE SODIUM, DIBASIC CALCIUM PHOSPHATE DIHYDRATE, FD-C RED NO. 40 ALUMINUM LAKE, HYPROMELLOSE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL, SODIUM BENZOATE, STEARIC ACID, TITANIUM DIOXIDE
Purpose
| Stool Softener
Stimulant Laxative |
Indications And Usage
RELIEVES OCCASIONAL CONSTIPATION GENERALLY PRODUCES BOWEL MOVEMENT IN 6-12 HOURS |
Warnings
DO NOT USE LAXATIVE PRODUCTS FOR LONGER THAN 1 WEEK UNLESS DIRECTED BY A DOCTOR IF YOU ARE PRESENTLY TAKING MINERAL OIL UNLESS DIRECTED BY A DOCTOR |
Dosage And Administration
| ADULTS AND CHILDREN 12 YEARS AND OVER: 2-4 TABLETS ONCE DAILY OR IN DIVIDED DOSES
CHILDREN 6 TO UNDER 12 YEARS: 1-2 TABLETS ONCE DAILY OR IN DIVIDED DOSES CHILDREN 2 TO UNDER 6 YEARS; 1/2 -1 TABLET ONCE DAILY OR IN DIVIDED DOSES CHILDREN UNDER 2 YEARS: ASK A DOCTOR |
Keep Out Of Reach Of Children
| KEEP OUT OF REACH OF CHILDREN. iN CASE OF OVERDOSE, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY |
Principal Display Panel
209r Label (209r)
* Please review the disclaimer below.
